These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1442019)

  • 1. Clinical application of exogenous surfactant and high frequency oscillation in Japan.
    Tamura M
    Acta Paediatr Jpn; 1992 Oct; 34(5):491-3. PubMed ID: 1442019
    [No Abstract]   [Full Text] [Related]  

  • 2. Respiratory distress syndrome in the newborn: innovative therapies.
    Wiswell TE; Mendiola J
    Am Fam Physician; 1993 Feb; 47(2):407-14. PubMed ID: 8430594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early nasal continuous positive airway pressure with or without prophylactic surfactant therapy in the premature infant with respiratory distress syndrome.
    Schimmel MS; Hammerman C
    Pediatr Radiol; 2000 Oct; 30(10):713-4. PubMed ID: 11075609
    [No Abstract]   [Full Text] [Related]  

  • 4. High frequency oscillation and exogenous surfactant in the treatment of neonatal respiratory distress syndrome.
    Claris O; Salle BL
    Acta Paediatr; 1997 Apr; 86(4):339-41. PubMed ID: 9174215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant therapy: more evidence of effectiveness.
    Averell C
    Pediatrics; 1995 Mar; 95(3):456. PubMed ID: 7710548
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of high frequency oscillatory ventilation in the treatment of acute respiratory distress syndrome].
    Zhan QY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):740-1. PubMed ID: 18218202
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of exogenous surfactant during conventional and high-frequency oscillatory ventilation in preterm infants with RDS.
    Vento G; Tana M; Tirone C; Aurilia C; Lio A; Perelli S; Ricci C; Romagnoli C
    Acta Biomed; 2013; 84 Suppl 1():25-7. PubMed ID: 24049958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy in high-risk congenital diaphragmatic hernia.
    Bos AP; Tibboel D; Hazebroek FW; Molenaar JC; Lachmann B; Gommers D
    Lancet; 1991 Nov; 338(8777):1279. PubMed ID: 1682679
    [No Abstract]   [Full Text] [Related]  

  • 9. A prospective, randomized, multicenter trial of high-frequency oscillatory ventilation compared with conventional ventilation in preterm infants with respiratory distress syndrome receiving surfactant.
    Rettwitz-Volk W; Veldman A; Roth B; Vierzig A; Kachel W; Varnholt V; Schlösser R; von Loewenich V
    J Pediatr; 1998 Feb; 132(2):249-54. PubMed ID: 9506636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFV: applied technology, saving both lives and costs.
    Bachman T; Lassen G
    Neonatal Intensive Care; 1993; 6(5):34-8. PubMed ID: 10146589
    [No Abstract]   [Full Text] [Related]  

  • 11. Surfactant therapy in neonatal respiratory distress syndrome.
    Nagesh K; Bhat V; Kunikullaya S; Rajesh N
    Indian Pediatr; 1994 Aug; 31(8):971-7. PubMed ID: 7883350
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular aspects of pulmonary surfactant in neonatal respiratory distress syndrome and surfactant replacement therapy].
    Chida S; Fujiwara T
    Nihon Rinsho; 1996 Feb; 54(2):346-52. PubMed ID: 8838080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant treatment for premature babies--a review of clinical trials.
    Morley CJ
    Arch Dis Child; 1991 Apr; 66(4 Spec No):445-50. PubMed ID: 2025043
    [No Abstract]   [Full Text] [Related]  

  • 14. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome.
    Moriette G; Paris-Llado J; Walti H; Escande B; Magny JF; Cambonie G; Thiriez G; Cantagrel S; Lacaze-Masmonteil T; Storme L; Blanc T; Liet JM; André C; Salanave B; Bréart G
    Pediatrics; 2001 Feb; 107(2):363-72. PubMed ID: 11158471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methods advance treatment for respiratory distress syndrome.
    Krauss AN
    Pediatr Ann; 2003 Sep; 32(9):585-91. PubMed ID: 14508892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First intention high-frequency oscillatory and conventional mechanical ventilation in premature infants without antenatal glucocorticoid prophylaxis.
    Salvo V; Zimmermann LJ; Gavilanes AW; Barberi I; Ricotti A; Abella R; Frigiola A; Giamberti A; Florio P; Tagliabue P; Tina LG; Nigro F; Temporini F; Gazzolo D
    Pediatr Crit Care Med; 2012 Jan; 13(1):72-9. PubMed ID: 21499177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high frequency oscillatory ventilation (HFOV) for respiratory distress syndrome (RDS).
    Stewart DL; Hilbert T
    J Ky Med Assoc; 1999 Jan; 97(1):17-21. PubMed ID: 9973781
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic review of prophylactic vs rescue surfactant.
    Morley CJ
    Arch Dis Child Fetal Neonatal Ed; 1997 Jul; 77(1):F70-4. PubMed ID: 9279189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.